Learn more about the different phases of clinical trials.
After demonstrating patient benefit and safety, Biogen submits the new drug to the FDA for registration and approval. Once we get approval, we manufacture the new treatment in large quantities. Our quality team manages compliance and supervises consistent and dependable production. At the same time, our supply chain group makes sure that we are able to get our therapies to patients. These skills allow us to supply medicines to appropriate patients in over 90 countries.
Here is an example of what the overall process looks like:
Thanks to advancements in tools and technology, we are looking at the human body in a whole new way. Throughout the discovery and development process, we may uncover things that lead to new information about MS and treatments. However, it’s not always smooth sailing. There are times when we find a dead end or run into setbacks. This isn’t always a bad thing. It may lead us down a new route. It may force us to take a step back and look again at the way we’re doing things. These challenges can be disappointing, but they're an important part of a complex research and development process. Both the setbacks and successes provide invaluable data. They help guide us to find our next potential treatment.
Learn more about the common types of relapsing MS treatment.
Like Above MS on Facebook to connect with the MS community.
From Dr. Coyle—Neurologist
This site is intended for US residents aged 18 and older.
© 2018 Biogen. All rights reserved.
Sign in to Above MS™ and take advantage of all the helpful features our site has to offer—like receiving recommended articles.
Not a member? Join now
Log in to your profile:
Enter your email address above and we’ll send you your password.
Email containing temporary password has been sent.
This link will take you to a website that is outside the control of Biogen. We provide links as a public service and for informational purposes only. We do not make or imply any endorsement of external websites.
Learn more about prescription treatment options for relapsing MS.